Related Experiment Video
Updated: Jul 11, 2026

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
Solid form selection of zwitterionic 5-HT4 receptor agonist
Takashi Kojima1, Kiyohiko Sugano, Satomi Onoue
1Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan Inc., Aichi 470-2393, Japan. tak_kojimajpn@yahoo.co.jp
The study identified multiple solid forms of a zwitterionic pharmaceutical compound (compound A). The besylate salt (BSA-I) demonstrated superior stability and manufacturability compared to earlier forms.
Area of Science:
- Pharmaceutical Science
- Solid-State Chemistry
Background:
- Discovery synthesis of zwitterionic compound A yielded multiple solid forms (ZW-I, ZW-II, ZW-III, ZW-IV).
- The initially stable ZW-I form degraded to a hydrate (ZW-IV) under ambient conditions due to moisture uptake.
Purpose of the Study:
- To select an optimal solid form of compound A for further development.
- To evaluate the stability and manufacturability of various salt forms.
Main Methods:
- Solid-state characterization of compound A and its salts.
- Salt screening using a 96-well plate format.
- Polymorph and hydrate screening.
- Chemical and physical stability assessments under various conditions.
Main Results:
- Multiple anhydrous and hydrate forms of compound A were identified.
- Besylate, camsylate, hemi-edisylate, hemifumarate, and monosuccinate salts were prepared and evaluated.
- The besylate salt form (BSA-I) exhibited excellent chemical and physical stability, particularly at high relative humidity, outperforming ZW-I.
Conclusions:
- The besylate salt form (BSA-I) was selected as the most promising solid form for compound A due to its enhanced stability and manufacturability.
- BSA-I offers significant improvements in physical stability compared to the ZW-I form.
More Related Videos
12:21Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...